Endocrine Abstracts

Renin angiotensin system blockers are currently used in the treatment of diabetic nephropathy. Carvedilol, 3. generation beta-blockers, may provide additional benefits in diabetic patients. Its antiproteinuric activity is not investigated in patients with diabetic nephropathy. We aimed to compare short-term additive effects of losartan with cilazapril or carvedilol combination on blood pressure, proteinuria and renal functions in microalbuminuric patients with type 2 diabetes ...

In hypertensive diabetic patients, renal angiotensin system blockers are first preferred due to their antihypertensive and antiproteinuric activities. Carvedilol, a third generation beta blocker, may provide additional benefits in diabetic patients. We aimed to compare the short-term efficacy of losartan treatment alone and in combination with cilazapril or carvedilol on blood pressure, glycemic control and lipid profile in microalbuminuric type 2 diabetic patients.<p clas...

In hypertensive diabetic patients, renal angiotensin system blockers are first preferred due to their antihypertensive and antiproteinuric activities. Carvedilol, a third generation beta blocker, may provide additional benefits in diabetic patients. We aimed to compare the short-term efficacy of losartan treatment alone and in combination with cilazapril or carvedilol on blood pressure, glycemic control and lipid profile in microalbuminuric type 2 diabetic patients.<p clas...